[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,058,542
  • Shares Outstanding, K 58,984
  • Annual Sales, $ 507,440 K
  • Annual Income, $ -187,690 K
  • EBIT $ -81 M
  • EBITDA $ -41 M
  • 60-Month Beta 0.78
  • Price/Sales 19.86
  • Price/Cash Flow N/A
  • Price/Book 14.77

Options Overview Details

View History
  • Implied Volatility 49.54% (+0.58%)
  • Historical Volatility 36.25%
  • IV Percentile 30%
  • IV Rank 20.47%
  • IV High 94.08% on 07/28/26
  • IV Low 38.07% on 08/12/25
  • Expected Move (DTE 16) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.92
  • Today's Volume 46
  • Volume Avg (30-Day) 610
  • Put/Call OI Ratio 2.92
  • Today's Open Interest 7,959
  • Open Int (30-Day) 4,110
  • Expected Range 169.86 to 169.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 5
  • High Estimate $-0.09
  • Low Estimate $-0.16
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) +18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
143.11 +18.54%
on 07/10/26
184.00 -7.80%
on 07/30/26
+21.30 (+14.36%)
since 07/02/26
3-Month
99.48 +70.53%
on 06/01/26
184.00 -7.80%
on 07/30/26
+36.22 (+27.15%)
since 05/05/26
52-Week
73.16 +131.88%
on 10/28/25
184.00 -7.80%
on 07/30/26
+81.58 (+92.64%)
since 08/05/25

Most Recent Stories

More News
Glaukos: Q2 Earnings Snapshot

Glaukos: Q2 Earnings Snapshot

GKOS : 169.95 (-0.34%)
Glaukos Announces Second Quarter 2026 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 169.95 (-0.34%)
Glaukos Earnings: Whether the iDose Launch Can Justify What's Already Been Priced In

Barchart Research What to Expect from GKOS Earnings GKOS Generated July 28, 2026 Current Price $151.33 EPS Estimate $$-0.28 Consensus Rating Strong Buy Average Move 11.64% Glaukos Earnings: Whether the...

GKOS : 169.95 (-0.34%)
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 169.95 (-0.34%)
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 169.95 (-0.34%)
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 169.95 (-0.34%)
Glaukos Announces Participation in Upcoming Investor Conferences

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 169.95 (-0.34%)
Glaukos: Q1 Earnings Snapshot

Glaukos: Q1 Earnings Snapshot

GKOS : 169.95 (-0.34%)
Glaukos Announces First Quarter 2026 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 169.95 (-0.34%)
Glaukos Reports Tomorrow With Epioxa Launch Metrics Still Unknown

Barchart Research What to Expect from GKOS Earnings GKOS Generated April 28, 2026 Current Price $119.63 EPS Estimate $$-0.30 Consensus Rating Strong Buy Average Move 9.55% Glaukos Reports Tomorrow With...

GKOS : 169.95 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 178.35
2nd Resistance Point 175.63
1st Resistance Point 173.08
Last Price 169.95
1st Support Level 167.81
2nd Support Level 165.09
3rd Support Level 162.54

See More

52-Week High 184.00
Last Price 169.95
Fibonacci 61.8% 141.66
Fibonacci 50% 128.58
Fibonacci 38.2% 115.50
52-Week Low 73.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.